FDA grants orphan drug designation to oral OCT-980 for RHO-adRP, now in phase 1b/2 testing at US sites. The FDA granted ...
Raphael Rostenne discusses what a good phone call looks like and contributes to successful patient interactions with host ...
The release noted that brepocitinib demonstrated consistent benefits in preventing treatment failure across key subgroups, ...
Drs Bryce St. Clair and Behrad Garmsiri explain how they build trust, improve health literacy, and destigmatize future ...
Open-access OCTA tools showed similar reliability, but different vessel density values in glaucoma; researchers advise using ...
From dry eye to GLP-1s, this year's conference brought a variety of insights from key experts in optometry. Want more ...
The Nobel Assembly at Karolinska Institutet announced that the 2026 Nobel Prize in Physiology or Medicine will be shared ...
Ryzumvi (phentolamine ophthalmic solution 0.75%) is approved for the treatment of presbyopia in adults. It is also approved for pharmacologically induced mydriasis produced by adrenergic agonists or ...
Zachary Keaney, CPOA, discusses the lens care steps patients skip most often and why early diagnosis of lens-related keratitis is critical. Contact lenses have come a long way since the earliest glass ...
Alcon's Brytly eye drops received FDA approval for OTC temporary relief of minor ocular redness. Alcon has received FDA approval for apraclonidine ophthalmic solution 0.125% (Brytly) redness relief ...
Interim 48-month data show 86% of patients with glaucoma or ocular hypertension remain off topical drops after a single cataract procedure, although the drop-free rate has eased from earlier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results